NCT04738890

Brief Summary

This study aims to conduct an initial evaluation of adapted, live online, mindfulness-based cognitive therapy for parents and carers of children with food allergies (MBCT-PCCFA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2021

Completed
26 days until next milestone

Study Start

First participant enrolled

March 2, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2022

Completed
Last Updated

December 17, 2024

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

February 1, 2021

Last Update Submit

December 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline at week 15 on the Food Allergy Quality of Life-Parental Burden scale - 17 item version (FAQL-PB)

    This measures quality of life in parents of children with food allergies producing a score between 17 and 119, with higher scores indicating a greater burden on the family.

    Post intervention (week 15)

Secondary Outcomes (13)

  • Change from baseline at week 23 on the Food Allergy Quality of Life-Parental Burden scale - 17 item version (FAQL-PB)

    Follow up (week 23)

  • Change from baseline at week 15 on the Generalized Anxiety Disorder screener - 7 items (GAD-7)

    Post intervention (week 15)

  • Change from baseline at week 23 on the Generalized Anxiety Disorder screener - 7 items (GAD-7)

    Follow up (week 23)

  • Change from baseline at week 15 on the Patient Health Questionnaire - 8 items (PHQ-8)

    Post intervention (week 15)

  • Change from baseline at week 23 on the Patient Health Questionnaire - 8 items (PHQ-8)

    Follow up (week 23)

  • +8 more secondary outcomes

Study Arms (2)

MBCT-PCCFA plus TAU

EXPERIMENTAL

Mindfulness-based cognitive therapy adapted for parents and carers of children with food allergy (MBCT-PCCFA) offered live online by video-conferencing, plus treatment as usual.

Behavioral: Mindfulness-based cognitive therapyOther: Treatment as usual

TAU control

OTHER

Treatment as usual control group

Other: Treatment as usual

Interventions

Mindfulness-based cognitive therapy adapted for parents and carers of children with food allergy (MBCT-PCCFA) offered live online by video-conferencing

MBCT-PCCFA plus TAU

Continuance as planned of whatever other treatments or interventions the participants were receiving at the time of recruitment.

MBCT-PCCFA plus TAUTAU control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parents or caregivers who identify as having a child under the age of 18 with a food allergy
  • The allergy has been diagnosed by a qualified physician (e.g. GP or allergy specialist)
  • Mean score of \>=2 on the FAQL-PB, indicating they are at least 'somewhat limited/troubled' by their child's allergy (Cohen et al., 2004).
  • Resident in the United Kingdom
  • Have access to email, a PC/laptop/tablet with a webcam and microphone and internet access to allow videoconferencing

You may not qualify if:

  • They had consulted on the design and content of the intervention or study
  • They have already participated in a substantial mindfulness-based course
  • They are currently engaged or are planning to engage with another psychological intervention during the course of the study
  • They currently engage in regular mindfulness-based practice
  • They do not have the practical means and time available to be able to attend the intervention during the dates outlined on the information sheet and commit to at-home practice
  • They have scores \>19 on PHQ-8 (indicating 'severe' depressive symptom severity; Kroenke et al., 2009) or \>15 on GAD (indicating 'severe' level of anxiety; Spitzer et al., 2006)
  • They have a problem with alcohol or recreational drug misuse
  • They have experienced thoughts about harming themselves or others in the last 12 months
  • They have been given a diagnosis of psychosis
  • They are currently experiencing high levels of distress and/or currently feeling particularly fragile
  • They have experienced a bereavement of someone close to them in the last year or are continuing to experience continuing grief in relation to losing someone further back in time
  • They have had traumatic experiences that they continue to be troubled by (including, but not limited to, receiving diagnosis of post-traumatic stress disorder)
  • They experience significant difficulty being in a group with other people.
  • NB: for further details re the FAQL-PB and PHQ-8, please see the outcome measures section.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salomons Institute for Applied Psychology

Royal Tunbridge Wells, Kent, TN1 2YG, United Kingdom

Location

MeSH Terms

Interventions

Mindfulness-Based Cognitive TherapyTherapeutics

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Ellie Craig, MSc

    Canterbury Christ Church University

    PRINCIPAL INVESTIGATOR
  • Fergal Jones, PhD, PsychD

    Canterbury Christ Church University

    STUDY DIRECTOR
  • Christina Jones, PhD

    University of Surrey

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2021

First Posted

February 4, 2021

Study Start

March 2, 2021

Primary Completion

December 8, 2021

Study Completion

February 2, 2022

Last Updated

December 17, 2024

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

IPD will be available to other researchers on email request to the corresponding author after the study findings have been published in a peer reviewed journal.

Locations